Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
George Robert E. Insider Profile
4 Followers
George Robert E. , Director at Moleculin Biotech, holds 14.66K shares in Moleculin Biotech (Ticker: MBRX). Most recently, George Robert E. Bought $14,493 shares of Moleculin Biotech on Dec 27, 2023 for an estimated value of 10.00K.
George Robert E. has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of George Robert E. 's holdings
Insider Roles
Director
Roles that George Robert E. holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by George Robert E.
George Robert E. 's Trading History
List of latest transactions for each holding click on a transaction to see George Robert E. 's performance on stock
You May Also Like
George Robert E. insider profile FAQ
What is the percentage of profitable transactions made by George Robert E. ?
The percentage of profitable transactions made by George Robert E. is ―.
What is the average return per transaction made by George Robert E. ?
The average return per transaction made by George Robert E. is ―.
What stocks does George Robert E. hold?
George Robert E. holds: MBRX stocks.
What was George Robert E. ’s latest transaction?
George Robert E. latest transaction was an Informative Buy of $10.00K.
What was George Robert E. 's most profitable transaction?
George Robert E. ’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is George Robert E. 's role in Moleculin Biotech?
George Robert E. 's role in Moleculin Biotech is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.